Sree Kant is the Head of Strategy for Pfizer’s External Science & Innovation group, leading partnering strategy across different therapeutic areas/technologies and geographies. He is focused on innovative partnerships, especially in the early stages with different partners (VC, biotech, academia, and foundations) to drive emerging science and breakthrough technologies Before joining Pfizer, he was a Principal at the Boston Consulting Group advising large pharma and biotech on R&D strategy as well as large M&A. Sree has also worked with two healthcare startups and a generic pharmaceutical company in India and the UK. He has an MBA from the Indian Institute of Management, and an MPH from the Harvard School of Public Health.
You must be a CEO, Founder, CFO or President to attend this event.